Nutrients turn on key tumor signaling molecule, fueling resistance to cancer therapy

Tumors can leverage glucose and another nutrient, acetate, to resist targeted therapies directed at specific cellular molecules, according to Ludwig Cancer Research scientists studying glioblastoma, a deadly brain cancer. The findings demonstrate that nutrients can strongly affect the signaling molecules that drive tumors.